@mervekaya.blog's TRT content raises red flags we checked

What did @mervekaya.blog actually say?

Honestly? It's not entirely clear. The transcript from this video is largely incoherent, mixing personal anecdotes about someone who "looks like a moaning friend" with references to dogs, houses, and golf. There are no specific claims about testosterone replacement therapy, dosing, symptoms, or clinical outcomes that can be extracted and evaluated.

The caption frames this as "the story of failures" which suggests a personal narrative, possibly about a journey with TRT or hormone health. But the actual spoken content doesn't support that reading in any legible way. The hashtags include "trt" which places it in the testosterone replacement therapy category, but nothing in the transcript explicitly discusses testosterone, hypogonadism, or any hormone-related topic.

Without verifiable health claims, there is nothing here to fact-check in the traditional sense. What we can do is use this as a moment to address what accurate TRT content actually looks like.

Does the science back this up?

There is nothing scientifically verifiable in this transcript, so the better question is: what does the evidence actually say about TRT, given this video's categorical placement?

TRT is a legitimate, FDA-approved treatment for hypogonadism, defined as consistently low testosterone with accompanying symptoms. A 2018 meta-analysis by Corona et al. in the Journal of Sexual Medicine found that TRT significantly improved sexual function, mood, and body composition in men with confirmed hypogonadism. However, the same analysis noted that benefits are substantially smaller in men with low-normal testosterone who don't meet diagnostic criteria.

The Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine) remain the most rigorous data set we have. They showed modest improvements in sexual function and bone density, but did not demonstrate cardiovascular protection, and raised ongoing questions about prostate risk that still haven't been fully resolved.

The point is: TRT works for the right people, diagnosed correctly, monitored properly. Social media framing of it as a lifestyle optimization tool rather than a treatment for a medical condition is where things get scientifically shaky.

What did they get wrong (or right)?

Because the transcript contains no coherent medical claims, there is nothing to score as right or wrong in clinical terms. That itself is worth noting. A video categorized under TRT, with over 200,000 views, that communicates nothing clinically useful, is a missed opportunity at best and a contribution to health misinformation noise at worst.

What the creator appears to get right, by omission, is that they don't make dangerous unsupported claims. There is no recommended dose, no promise of a cure, no claim that compounded testosterone is equivalent to a brand-name product. That's a low bar, but in the TRT influencer space, it's a bar that gets cleared less often than you'd think.

What they get wrong is the framing. Hashtagging "trt" on content that is medically unintelligible means people searching for information about testosterone therapy may land here and come away no better informed, or worse, with the impression that this is what credible TRT discussion looks like.

What should you actually know?

If you're exploring TRT, the basics matter more than any influencer's personal narrative. Hypogonadism diagnosis requires at least two morning serum testosterone measurements below the lab's reference range, combined with clinical symptoms. A single low reading isn't enough. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) are explicit on this point.

Symptoms that warrant investigation include persistent fatigue, reduced libido, erectile dysfunction, loss of muscle mass, and mood changes. These symptoms are non-specific, meaning many conditions cause them. Jumping to TRT without ruling out thyroid dysfunction, sleep apnea, or depression is a clinical mistake.

Monitoring on TRT matters as much as starting it. Hematocrit, PSA, and lipid panels need regular review. If a provider isn't checking these, that's a red flag regardless of how good the before-and-after content looks on Instagram.